Literature DB >> 3138388

Some characteristics of threonine transport across the blood-brain barrier of the rat.

A Tovar1, J K Tews, N Torres, A E Harper.   

Abstract

Threonine entry into brain is altered by diet-induced changes in concentrations of plasma amino acids, especially the small neutrals. To study this finding further, we compared effects of various amino acids (large and small neutrals, analogues, and transport models) on transport of threonine and phenylalanine across the blood-brain barrier. Threonine transport was saturable and was usually depressed more by natural large than small neutrals. Norvaline and 2-amino-n-butyrate (AABA) were stronger competitors than norleucine. 2-Aminobicyclo[2.2.1]heptane-2-carboxylate (BCH), a model in other preparations for the large neutral (L) system, and cysteine, a proposed model for the ASC system only in certain preparations, reduced threonine transport; 2-(methylamino)isobutyrate (MeAIB; a model for the A system for small neutrals) did not. Phenylalanine transport was most depressed by cold phenylalanine and other large neutrals; threonine and other small neutrals had little effect. Norleucine, but not AABA, was a strong competitor; BCH was more competitive than cysteine or MeAIB. Absence of sodium did not affect phenylalanine transport, but decreased threonine uptake by 25% (p less than 0.001). Our results with natural, analogue, and model amino acids, and especially with sodium, suggest that threonine, but not phenylalanine, may enter the brain partly by the sodium-dependent ASC system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138388     DOI: 10.1111/j.1471-4159.1988.tb03098.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Teodoro Bottiglieri; K Michael Gibson
Journal:  Mol Genet Metab       Date:  2013-08-15       Impact factor: 4.797

2.  Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Teodoro Bottiglieri; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

3.  Blood-endothelial cell and blood-brain transport of L-proline, alpha-aminoisobutyric acid, and L-alanine.

Authors:  H Benrabh; J M Lefauconnier
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

4.  Dietary amino acids and incidence of hypertension: A principle component analysis approach.

Authors:  Farshad Teymoori; Golaleh Asghari; Parvin Mirmiran; Fereidoun Azizi
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

5.  Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology.

Authors:  Marine Tournissac; Milene Vandal; Cyntia Tremblay; Philippe Bourassa; Sylvie Vancassel; Vincent Emond; Anne Gangloff; Frederic Calon
Journal:  Alzheimers Dement (N Y)       Date:  2018-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.